Trillium Therapeutics Inc.

Connor, Clark & Lunn Investment Management Ltd.

Report date

9/30/2021

Quarter

2021 Q3

Filed

11/12/2021

Shares

20,200

Value ($000)

355

Weight

0.0%

2020 Q4 - 2021 Q3 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q3	11/12/2021	355	0.0%	20,200	9/30/2021
2021 Q2	8/12/2021	3,318	0.0%	342,500	6/30/2021
2021 Q1	5/13/2021	3,962	0.0%	369,900	3/31/2021
2020 Q4	2/16/2021	2,950	0.0%	200,500	12/31/2020